These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2866493)

  • 61. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.
    Mokhber N; Azarpazhooh MR; Khajehdaluee M; Velayati A; Hopwood M
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):128-33. PubMed ID: 20132529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder.
    Othmer E; Othmer SC
    J Clin Psychiatry; 1987 May; 48(5):201-3. PubMed ID: 2883173
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Halazepam and diazepam in neurotic anxiety: a double-blind study.
    Rickels K; Pereira-Organ J; Csanalosi I; Morris RJ; Rosenfeld H; Sablosky L; Schless A; Werblowsky JH
    Psychopharmacology (Berl); 1977 Apr; 52(2):129-36. PubMed ID: 18749
    [No Abstract]   [Full Text] [Related]  

  • 65. [Buspirone in the treatment of Generalized Anxiety Disorders].
    Rzewuska M; Sobucka K
    Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clobazam and diazepam in anxiety.
    Rickels K; Brown AS; Cohen D; Harris H; Hurowitz A; Lindenbaum EJ; Ross HA; Weinstock R; Wiseman K; Zal M
    Clin Pharmacol Ther; 1981 Jul; 30(1):95-100. PubMed ID: 6113074
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Open trial of buspirone in the treatment of major depressive disorder.
    Schweizer EE; Amsterdam J; Rickels K; Kaplan M; Droba M
    Psychopharmacol Bull; 1986; 22(1):183-5. PubMed ID: 2873610
    [No Abstract]   [Full Text] [Related]  

  • 68. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone.
    Feighner JP; Cohn JB
    Neuropsychobiology; 1989; 21(3):124-30. PubMed ID: 2615929
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Buspirone: an anxioselective alternative for the management of anxiety disorders.
    Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensive design in evaluating anxiolytic agents.
    Uhlenhuth EH; Turner DA; Purchatzke G; Gift T; Chassan J
    Psychopharmacology (Berl); 1977 Mar; 52(1):79-85. PubMed ID: 15297
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.
    Deberdt R
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):32-9. PubMed ID: 237742
    [No Abstract]   [Full Text] [Related]  

  • 76. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuroendocrine effects of buspirone in patients with generalized anxiety disorder.
    Cohn JB; Wilcox CS; Meltzer HY
    Am J Med; 1986 Mar; 80(3B):36-40. PubMed ID: 3963033
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting.
    Böhm C; Placchi M; Stallone F; Gammans RE; Alms DR; Shrotriya RC; Robinson DS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):38S-42S. PubMed ID: 1973939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo.
    Casacchia M; Bolino F; Ecari U
    Curr Med Res Opin; 1990; 12(4):215-23. PubMed ID: 1981698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.